Mendel Goldfinger
VapeAway · Montefiore/Einstein Cancer Center · Montefiore Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mendel Goldfinger as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:31 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07322432 · The CONQUER Trial - Cessation Of Nicotine, QUitting With E-cigarette ReductionVapeAway · recruiting · Addiction Nicotine · principal investigator
- Ph1NCT07006025 · A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS)Treebough Therapies · recruiting · MDS · principal investigator
- Ph2NCT05184842 · Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AMLMontefiore Medical Center · recruiting · Myelodysplastic Syndromes, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:31 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- Clinical Trials Assessing Hypomethylating Agents Combined with Other Therapies: Causes for Failure and Potential Solutions.Clin Cancer Res · 202135 citationsRCR 1.8
- Assessment of risk factors for emergence distress and postoperative behavioural changes in children following general anaesthesia.Paediatr Anaesth · 200422 citationsRCR 1.1
- 19 citationsRCR 3.9
- 15 citationsRCR 1.8
- Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.Clin Cancer Res · 20239 citationsRCR 1.0
- Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.Ann Pharmacother · 19978 citationsRCR 0.3